Resistance to second-line drugs in multidrug-resistant tuberculosis. Go to Publication You Might Also Like MDR, XDR, TDR tuberculosis: ominous progression. April 23, 2012 The N-95 mask: invaluable ally in the battle against the COVID-19 pandemic September 3, 2020 Pneumocystis pneumonia. September 20, 2004 The Lancet Respiratory Medicine Commission: 2019 update: epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant and incurable tuberculosis January 9, 2020 Bedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary Extensively Drug-Resistant Tuberculosis. October 23, 2017
The Lancet Respiratory Medicine Commission: 2019 update: epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant and incurable tuberculosis January 9, 2020
Bedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary Extensively Drug-Resistant Tuberculosis. October 23, 2017